ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2239

The Recall Program: Data from a Multicenter Educational Event on Patients with Rheumatoid Arthritis

Andrea Delle Sedie1, Emilio Filippucci2, Oscar Epis3, Pierluigi Macchioni4, Sebastiano Tropea5, Carlo Bonali6, Marco Canzoni7 and Annamaria Iagnocco8, 1Department Rheumatology, University of Pisa, Pisa, Italy, 2Rheumatology Unit, Università Politecnica delle Marche, Jesi, Italy, 3Rheumatology Unit, Ospedale Niguarda, Milano, Italy, 4Arcispedale Santa Maria Nuova, Reggio Emilia, Italy, 5ASP7, Busacca Hospital, Ragusa, Italy, 6Rheumatology Unit,, Ospedale San Paolo, Bari, Italy, 7Local Health Unit (ASL) Rome 1, Rome, Italy, 8Academic Rheumatology Unit, Università degli Studi di Torino, Torino, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Arthritis, Health Assessment Questionnaire, Rheumatoid arthritis (RA), synovial fluid and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Patient Outcomes, Preferences, and Attitudes Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: ultrasound (US) is able to show subclinical synovitis in patients (pts) with rheumatoid arthritis (RA) who are in clinical remission (CR); this has been proposed as a predictive factor for both clinical flares and progression of the structural damage in CR pts. The aim of this work was to investigate the US characteristics of RA pts presenting either CR or low disease activity (LDA).

Methods: in 2015 and 2016 an educational event focus on the added value of US in RA pts was held in 22 rheumatology centers in Italy. After a brief presentation on the evidence of the added value of US for the clinician given by expert sonographers (rheumatologists with a special interest in US who were performing US as their usual activity since many years), in every center, the local rheumatologists provided RA pts to be examined by US. All of the US machine were identical both for type (Logiq E R7, General Electrics, with a 4.2-13 MHz linear probe) and settings (both for grey-scale and power Doppler (PD)). Pts signed an informed consent and a brief history of them was collected by the local rheumatologists (previous and current therapy, DAS28, HAQ score). The US examination was performed bilaterally on wrists, MCP and MTP joints, looking for synovitis (effusion, synovial proliferation and PD) and erosions. The positive findings were scored according to a 0-3 score for synovitis components and presence/absence for erosions; the number and dimensions of the largest erosion were also registered.

Results: demographic and descriptive data of the 1466 pts examined are reported in Table I. Pts were divided on the basis of the DAS28 result. A statistically significant difference in age was registered between the group in CR and the group with DAS28>3.2 (p=0.003), while no differences were found for HAQ or MTX use. Higher prevalence of findings (regardless the score) was present in LDA group with respect to the CR one for effusion, synovial proliferation, PD and erosions, with significant differences for effusion (global, wrist, MCP and MTP joints; p=0.001, 0.024, 0.001 and 0.000 respectively), synovial proliferation effusion (global, wrist and MTP joints; p=0.019, 0.005, and 0.029 respectively), PD positivity (global, wrist, MCP and MTP joints; p=0.000, 0.000, 0.001, and 0.000 respectively) and erosions (global and MCP joints; p=0.009 and 0.000 respectively).

Table I: demographic data

DAS28 <2.6

DAS28 2.6-3.2

DAS28>3.2

N (M:F)

271 (69:202)

323 (70:253)

139 (26:113)

Age (mean±SD; yy)

56.6±13.9

59.2±11.7

61.0±11.1

Disease duration (mean±SD; dd)

2619.08±2686.78

2850.47±2509.29

2046.39±1951.16

Conclusion: in this large group of RA pts, US showed frequent abnormalities both in the CR and in the LDA group. Our results are in line with previous studies and confirm that US is a useful imaging tool for the detection of subclinical joint abnormalities in RA.


Disclosure: A. Delle Sedie, None; E. Filippucci, None; O. Epis, None; P. Macchioni, None; S. Tropea, None; C. Bonali, None; M. Canzoni, None; A. Iagnocco, None.

To cite this abstract in AMA style:

Delle Sedie A, Filippucci E, Epis O, Macchioni P, Tropea S, Bonali C, Canzoni M, Iagnocco A. The Recall Program: Data from a Multicenter Educational Event on Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/the-recall-program-data-from-a-multicenter-educational-event-on-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-recall-program-data-from-a-multicenter-educational-event-on-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology